Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients

CONCLUSION: Poor survival in cachexia patients suggests a negative relationship between cachexia and ICI efficacy. In clinical practice, the existence of cachexia should be estimated to choose individuals who may benefit from ICIs.PMID:38466657 | DOI:10.18632/aging.205652

Source: Aging - March 11, 2024 Category: Biomedical Science Authors: Yean Yu Li Yan Tianhui Huang Zhenfu Wu Juan Liu Source Type: research